insights_auto
Why is CSBR down 3.30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$4.44
arrow_downward
-3.30%(-0.15) 1D
Nov 18, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
61.82M
Avg. vol.
7.41K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
61.82M
Avg. vol.
7.41K
Volume
0.00
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
TradingView
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Chattanooga Times Free Press
·
1 hour ago
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
BigGo Finance
·
2 hours ago
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
2 hours ago
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com